—Antares Therapeutics revealed $177 million in financing to support a preclinical pipeline of assets from Scorpion Therapeutics. Eli Lilly acquired Scorpion earlier this year to get one drug, a ...

The startup is one of several that have recently raised mega rounds of financing to support programs in the clinic or ...

LLY's $1.3 billion Verve deal marks its third M&A in 2025 as it pushes to diversify across cardiovascular, neuro and cancer ...

Eli Lilly has unveiled a $2.5 billion deal to acquire rights to a cancer therapy being developed by Scorpion Therapeutics in a third major transaction announced on the first day of the JP Morgan ...

GlaxoSmithKline's head of oncology Axel Hoos has resigned from the company, and will take up a new role as chief executive of US biotech Scorpion Therapeutics. Hoos is leaving GSK after nine years ...

A high-level overview of Viking Therapeutics, Inc. (VKTX) stock. View (VKTX) real-time stock price, chart, news, analysis, analyst reviews and more.

VistaGen Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.43, expectations were $-0.52. Operator: Good day, everyone, and thank you for standing by. Welcome to the Vistagen ...

Read about Applied Therapeutics Inc (APLT:XNAS) stock and today's latest news and financial updates. APLT - Applied Therapeutics Inc News | Morningstar Morningstar brands and products ...

Therapeutics are treatments used to alleviate or prevent a particular disease. Examples of therapeutics include drug therapy, medical devices, nutrition therapy and stem-cell therapies ...